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682Background: Changes in postoperative serum creatinine levels have been used to define acute renal injury in
patients undergoing cardiac surgery with cardiopulmonary bypass. It remains unclear, however, whether sub-
clinical increases in serum creatinine that do not meet current Acute Kidney Injury Network or RIFLE (risk,
injury, failure, loss, and end-stage kidney disease) criteria for acute renal injury are predictive of mortality after
cardiac surgery.
Methods:Multivariate logistic regression was performed in a retrospective cohort of 3914 consecutive patients
undergoing primary, isolated coronary artery bypass grafting with cardiopulmonary bypass to determine
whether postoperative serum creatinine change independently predicts 30-day all-cause mortality in patients
with normal renal function and with varying levels of preoperative renal insufficiency. To control further for
selection bias, multivariate logistic regression was performed on a propensity-matched cohort (n¼ 2042) to de-
termine whether subclinical increases in serum creatinine predict mortality.
Results:Negative change in serum creatinine was associated with reduced 30-day all-cause mortality. Even sub-
clinical increases in serum creatinine were associated with increased mortality relative to patients with negative
changes in serum creatinine (odds ratio, 3.93; 95% confidence interval, 1.68–9.22; P<.01). After propensity
matching, subclinical increases in serum creatinine were still associated with increased mortality (odds ratio,
4.13; 95% confidence interval, 1.37–12.45; P ¼ .01).
Conclusions: Subclinical increases in serum creatinine that do not meet acute renal injury criteria are indepen-
dently associated with 30-day all-cause mortality in patients with normal renal function or preoperative renal
insufficiency undergoing coronary artery bypass grafting. (J Thorac Cardiovasc Surg 2012;143:682-8)Supplemental material is available online.Preoperative renal insufficiency (RI) has been shown to be
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The Journal of Thoracic and Cardiovascular Surgafter surgery.1,2 In contrast, few data exist to determine
whether the postoperative change in serum creatinine is
independently associated with mortality after cardiac
surgery in patients with normal preoperative renal
function (RF) and varying degrees of preoperative RI.3-5
Moreover, it remains unclear whether subclinical changes
in postoperative serum creatinine levels, changes that do
not meet current diagnostic criteria for acute kidney
injury (AKI), as defined by Acute Kidney Injury Network
(AKIN)6 or RIFLE7 (risk, injury, failure, loss, and end-
stage kidney disease) criteria (Table E1), may still affect
outcomes after cardiac surgery.
Recently, Lassnigg and colleagues3,4 found that small
changes in postoperative serum creatinine levels are
associated with increased mortality after cardiac surgery.
Their study did not control for varying degrees of
preoperative RI, however, and was potentially
confounded by the inclusion of multiple types of
cardiothoracic operations. Because postoperative serum
creatinine levels vary with baseline RF, it is important to
assess change in serum creatinine as a biomarker across
the spectrum of preoperative RF. In a retrospective cohort
(n ¼ 3914) of patients undergoing primary, isolated
coronary artery bypass grafting (CABG) with
cardiopulmonary bypass (CPB) at a single institution, weery c March 2012
Abbreviations and Acronyms
AKI ¼ acute kidney injury
AKIN ¼ Acute Kidney Injury Network
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
CPB ¼ cardiopulmonary bypass
GFR ¼ glomerular filtration rate
OR ¼ odds ratio
RF ¼ renal function
RI ¼ renal insufficiency
RIFLE ¼ risk, injury, failure, loss, and end-stage
kidney disease
Tolpin et al Perioperative Managementinvestigated whether subclinical postoperative serum
creatinine change independently predicts 30-day all-cause
mortality in patients with normal RF and with varying levels
of preoperative RI.P
MMATERIALS AND METHODS
Study Subjects
A retrospective cohort study was performed on all consecutive patients
(n¼ 3914) undergoing primary, isolated CABGwith CPB between January
2002 and January 2008 at the Texas Heart Institute, St Luke’s Episcopal
Hospital. Institutional review board approval was obtained. Patients were
classified into 4 groups according to preoperative RF by applying the ab-
breviated Modification of Diet in Renal Disease study equation8: normal
was a glomerular filtration rate (GFR) of at least 90 mL/min per 1.73 m2
(n ¼ 714); mild RI was a GFR of 60 to 89 mL/min per 1.73 m2
(n ¼ 2085); moderate RI was a GFR of 30 to 59 mL/min per 1.73 m2
(n ¼ 951); and severe RI was a GFR less than 30 mL/min per 1.73 m2
(n ¼ 164). Patients undergoing repeat sternotomy or CABG combined
with other cardiac procedures (atrial septal defect repair, valve repair or re-
placement, and so on) were excluded from the study. Patients receiving pre-
operative dialysis were also excluded.
Data Collection
Patient demographic characteristics, risk factors, and serum creatinine
levels were obtained from the Texas Heart Institute cardiac surgical data-
base. Preoperative serum creatinine levels were defined as the highest cre-
atinine level within 48 hours before surgery. Postoperative serum
creatinine levels were defined as the peak serum creatinine level within
48 hours after surgery. Change in serum creatinine was defined as the dif-
ference between the peak postoperative and preoperative serum creatinine
levels. The measured end point was 30-day all-cause mortality.
Statistical Analyses
All statistical analyses were performed with SAS statistical software
(version 9.1; SAS Institute, Cary, NC) by the Division of Biostatistics
and Epidemiology, Texas Heart Institute, Houston, Texas. Continuous vari-
ables were expressed as the mean  SD, and categoric (frequency) vari-
ables were expressed as percentages. Univariate logistic regression
analyses were initially conducted to evaluate whether there were
between-group differences in patient preoperative demographic character-
istics, risk factors, and preoperative medications (Table 1).
To assess the influence of preoperative baseline RF on perioperative
mortality, multivariate stepwise logistic regression was first performedThe Journal of Thoracic and Caon all patients to determine whether the severity of preoperative RI was in-
dependently associated with 30-day all-cause mortality after CABG with
CPB. Multivariate stepwise logistic regression was then performed on
each group to determine whether the postoperative change in serum creat-
inine as a continuous variable was independently associated with 30 day
all-causemortality. Only those variables statistically significant at a P value
less than .05 were retained within the final model. Odds ratios (ORs), cor-
responding 95% confidence intervals (CIs), and associated P values are
reported.
To categorize further the impact of subclinical changes in serum creat-
inine, patients were then divided into 3 groups: Group A consisted of pa-
tients with a negative change in serum creatinine (0.1 mg/dL;
n¼ 1762); group B consisted of patients with postoperative AKI as defined
by AKIN6 or RIFLE7 criteria (change in serum creatinine 0.3 mg/dL or
150% increase from baseline; n ¼ 472); and group C consisted of pa-
tients with a subclinical increase in serum creatinine that did not meet
the AKIN6 or RIFLE7 AKI criteria (change in serum creatinine 0–0.2
mg/dL with<150% increase in creatinine from baseline; n ¼ 1494). Step-
wise, multivariate logistic regression analysis was then performed to deter-
mine an association with 30-day all-cause mortality. Finally, in an attempt
to control further for selection bias and to determine whether a subclinical
increase in serum creatinine was associated with 30-day all-cause mortal-
ity, conditional logistic regression was also performed on a propensity
score–matched cohort of group A patients (n¼ 1021) and group C patients
(n ¼ 1021). Propensity scores for patients in groups A and C were devel-
oped by using multivariate logistic regression modeling. A greedy algo-
rithm was used to match cases in group C with those in group A. The
presented algorithm also used the nearest available pair matching method.
The matching process was automatically performed by the previously de-
scribed SAS statistical software. Table 2 contains a list of 31 of the 44 vari-
ables used to determine each subject’s propensity score. We estimated that
with a sample size of 860 patients for each group, the study should have
80% power to detect significant difference of the mortality between group
A and group C. After the propensity matching, patient preoperative demo-
graphic characteristics, risk factors, and preoperative medications were
compared between groups by McNemar test for categoric variables and
by paired t test for continuous variables.
RESULTS
Eighteen patients were excluded from the analyses be-
cause of missing postoperative serum creatinine levels.
Table 1 displays patient demographic characteristics and
perioperative risk factors for patients with normal RF and
patients with mild, moderate, and severe RI. As expected,
worsening RF was associated with more preoperative co-
morbidity. Specifically, patients with severe RI were more
likely to be older than 65 years, to require urgent surgery,
to have diabetes or hypertension, to have an ejection frac-
tion less than 50%, and to have a diagnosis of congestive
heart failure or stroke. In addition, increased severity of
RF was more common among women and was associated
with a higher likelihood of receiving medical therapy for
comorbid conditions (b-blockers and calcium-channel
blockers).
Relative to patients with normal preoperative RF, patients
with mild preoperative RI did not have an increased 30-day
all-cause mortality (1.3% vs 1.4%). In contrast, both mod-
erate preoperative RI (OR, 2.54; 95% CI, 1.09–5.89;
P ¼ .03) and severe preoperative RI (OR, 5.14; 95% CI,
2.02–13.06; P< .01) were independently associated withrdiovascular Surgery c Volume 143, Number 3 683
TABLE 1. Perioperative demographic characteristics and risk factors in patients with normal renal function and varying levels of renal
insufficiency
Normal RF
(n ¼ 714)
Mild RI
(n ¼ 2085)
Moderate RI
(n ¼ 951)
Severe RI
(n ¼ 164)
Age>65 y 13.5% 33.1%* 38.4%* 32.3%*
Female 18.5% 20.6% 35.0%* 39.6%*
Smoker 53.5% 48.3% 48.1% 45.7%
Urgent surgery 24.0% 24.8% 26.4% 31.7%*
Obesity (body mass index>30 kg/m2) 40.9% 37.7% 39.9% 38.4%
Diabetes 41.7% 34.2%* 42.9% 78.7%*
Hypertension 79.0% 80.3% 89.3%* 92.7%*
Triple-vessel disease 53.2% 55.0% 58.4%* 59.2%
Left main disease 24.0% 27.0% 30.0%* 34.2%*
Previous myocardial infarction 40.3% 36.9% 36.0% 52.4%*
Unstable angina 43.7% 42.8% 41.22%* 36.0%
Ejection fraction<50% 29.3% 30.4% 28.3% 47.0%*
Valve disease 4.3% 6.5%* 8.7%* 15.2%*
Congestive heart failure 13.3% 16.5%* 26.3%* 59.8%*
Transient ischemic attack 1.8% 3.1% 4.7%* 1.8%
Stroke 2.0% 5.0%* 9.9%* 14.0%*
Pulmonary disease 23.5% 25.5% 31.6%* 39.6%*
Peripheral vascular disease 9.8% 14.7%* 25.3%* 40.2%*
Preoperative intra-aortic balloon pump 3.5% 3.4% 4.5% 4.3%
Preoperative b-blocker 48.7% 53.8% 57.5%* 62.2%*
Preoperative angiotensin-converting enzyme Inhibitor 44.4% 45.0% 53.8%* 42.1%
Preoperative calcium-channel blocker 16.7% 16.3% 22.4%* 33.5%*
Preoperative aspirin (INN acetylsalicylic acid) 62.4% 67.1%* 64.6% 57.3%
Preoperative statin 56.2% 60.9%* 63.5%* 49.1%
Preoperative clopidogrel bisulfate (INN clopidogrel) 18.8% 22.4%* 23.7%* 22.0%
Aortic crossclamp time (min, mean  SD) 42  22 43  24 43  27 43  26
Total bypass time (min, mean  SD) 73.  35. 73  38 74  36 75  38
Except as noted, numbers represent percentages of patients. RF, Renal function; RI, renal insufficiency. *P<.05 relative to patients with normal renal function.
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M30-day all cause mortality (3.5% and 11.6%, respectively).
Multivariate logistic regression analysis of risk factors for
30-day all-cause mortality is shown in Figure 1.
Multivariate logistic regression was then performed to
determine whether the postoperative change in serum creat-
inine as a continuous variable was independently associated
with 30-day all-cause mortality. In patients with normal pre-
operative RF, change in serum creatinine was independently
associated with an increased 30-day all-cause mortality
(OR, 6.84; 95% CI, 2.81–16.63; P<.01). Change in serum
creatinine was also a significant predictor of 30-day all-
cause mortality in patients with mild preoperative RI (OR,
16.3; 95% CI, 7.60–34.97; P<.01) and moderate preoper-
ative RI (OR, 2.59; 95% CI, 1.60–4.18; P<.01). In con-
trast, change in serum creatinine was not associated with
an increased risk of 30-day all cause mortality in patients
with severe preoperative RI (OR, 0.88; 95% CI, 0.68–
1.15; P ¼ .35). Figure 2 displays the incidence of 30-day
all-cause mortality for each level of change in serum creat-
inine in a combined group of patients with normal RF, mild
preoperative RI, and moderate preoperative RI. Patients684 The Journal of Thoracic and Cardiovascular Surgwith a negative change in serum creatinine accounted for
47% of the patient population who underwent CABG
with CPB and had the lowest 30-day all-cause mortality
at 0.45% (n ¼ 1762). A stepwise increase in mortality
was observed when the level of change in serum creatinine
increased from 0 to 0.4 mg/dL, above which threshold mor-
tality increased exponentially.
To categorize the impact of subclinical changes in serum
creatinine, patients were then divided into 3 groups. Group
A consisted of patients with a negative change in serum cre-
atinine (0.1 mg/dL; n ¼ 1762); group B consisted of pa-
tients with postoperative AKI as defined by AKIN6 and
RIFLE7 criteria (change in serum creatinine 0.3 mg/dL
or 150% increase from baseline; n ¼ 472); and group C
consisted of patients with a subclinical increase in serum
creatinine that did not meet the AKIN6 or RIFLE7 AKI cri-
teria (change in serum creatinine 0–0.2 mg/dL with<150%
increase in creatinine from baseline; n¼ 1494). The 30-day
all-cause mortalities were 0.45% in group A, 1.61% in
group C, and 8.26 in group B. Stepwise, multivariate logis-
tic regression analysis was performed to determine whetherery c March 2012
TABLE 2. Perioperative demographic variables and risk factors in
propensity-matched cohorts (n ¼ 2042)
Group A
(n ¼ 1021)
Group C
(n ¼ 1021)
P
value
Age>65 y 45.5% 45.4% .93
Female 23.8% 23.0% .68
Normal preoperative renal function 18.4% 19.2% .90
Mild preoperative renal insufficiency 62.4% 61.6% .90
Moderate preoperative renal
insufficiency
19.2% 19.2% .90
Smoker 51.6% 48.3% .13
Urgent surgery 23.3% 25.0% .38
Obesity (body mass index>30 kg/m2) 39.6% 39.4% .93
Diabetes 35.6% 37.2% .46
Hypertension 85.1% 84.8% .85
Triple-vessel disease 53.3% 53.5% .59
Left main disease 25.2% 25.8% .76
Previous myocardial infarction 35.5% 36.3% .68
Unstable angina 44.8% 42.2% .25
Valvular heart disease 5.9% 6.3% .71
Congestive heart failure 15.4% 14.2% .45
History of transient ischemic attack 2.6% 2.3% .66
History of stroke 5.4% 5.2% .84
Carotid artery disease 32.2% 32.6% .85
Peripheral vascular disease 13.6% 15.3% .29
Pulmonary disease 24.7% 25.6% .65
Preoperative intra-aortic balloon pump 1.9% 1.8% .87
Preoperative b-blocker 53.1% 51.6% .51
Preoperative calcium-channel blocker 17.0% 18.5% .39
Preoperative angiotensin-converting
enzyme inhibitor
47.8% 49.66% .40
Preoperative aspirin (INN
acetylsalicylic acid)
67.1% 66.6% .81
Preoperative statin 61.2% 59.8% .50
Preoperative clopidogrel bisulfate (INN
clopidogrel)
22.1% 22.3% .92
Preoperative diuretics 20.7% 23.3% .15
Crossclamp time (min, mean  SD) 39  22 40  22 .31
Total bypass time (min, mean  SD) 69  33 72  35 .66
Except as noted, numbers represent percentages of patients. Group A includes pa-
tients with negative change in serum creatinine (0.1 mg/dL); group C includes pa-
tients with no change or subclinical increase in change in serum creatinine without
acute kidney injury (change in serum creatinine 0–0.2 mg/dL with<150% increase
in serum creatinine from baseline).
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M30-day all-cause mortality differed between group A pa-
tients and group B or C patients. This analysis revealed
that not only were patients with postoperative AKI (group
B) at a significantly increased risk of 30-day all-cause mor-
tality (OR, 14.69; 95% CI, 6.42–33.62; P<.01), but also
subclinical increase in serum creatinine (group C) was inde-
pendently associated with an increased risk of 30-day all-
cause mortality (OR, 3.93; 95% CI, 1.684–9.22; P<.01).
ORs, corresponding 95% CIs, and associated P values for
all significant predictors of 30-day all-cause mortality for
this analysis are presented in Figure 3. The c statistic for
this analysis was 0.84.The Journal of Thoracic and CaIn an attempt to control further for selection bias related
to change in serum creatinine and to determine whether
a subclinical increase in serum creatinine was indepen-
dently associated with an increased risk of 30-day all-
cause mortality, conditional logistic regression was also
performed on a propensity score–matched cohort of 2042
patients between group A patients (n ¼ 1021) and group
C patients (n ¼ 1021). Table 2 demonstrates that no signif-
icant differences existed in these variables between group A
and group C patients. After controlling for propensity score,
group C patients (with a subclinical increase in serum cre-
atinine) were still found to be independently associated
with an increased risk of 30-day all-cause mortality relative
to group A patients (with a negative change in serum creat-
inine; 1.57% vs 0.39%; OR, 4.13; 95% CI, 1.37–12.45;
P ¼ .01). This propensity score–matched analysis thus fur-
ther supports our hypothesis that a subclinical postoperative
change in serum creatinine may independently predict 30-
day all-cause mortality after CABG with CPB.
DISCUSSION
Serum creatinine has long been used as a biomarker for
RF, and more recently it has been used for preoperative
risk stratification.1,2,9-11 Consistent with previous findings,
our data demonstrate that both moderate and severe
preoperative RI were associated with increased
perioperative mortality after CABG with CPB.12,13 Few
data exist to date, however, as to whether the
postoperative change in serum creatinine serves as an
independent biomarker for mortality after cardiac surgery
in patients with varying degrees of preoperative RI.
Because postoperative serum creatinine levels vary with
baseline RF, it is important to assess change in serum
creatinine as a biomarker across the spectrum of
preoperative RF. We have now demonstrated that in the
population undergoing primary isolated CABG with CPB
postoperative change in serum creatinine is an
independent predictor of 30-day all-cause postoperative
mortality for patients with preoperative normal RF, mild
RI, or moderate RI, but not in patients with preoperative se-
vere RI. Moreover, unlike previous studies that have fo-
cused solely on clinically significant positive changes in
postoperative creatinine, we also demonstrated that a nega-
tive change in serum creatinine after CABGwith CPB is as-
sociated with the lowest mortality and that even small,
subclinical positive increases in change in serum creatinine
that do notmeet the AKI criteria as defined by AKIN6 or RI-
FLE7 criteria (change in serum creatinine 0–0.2 mg/dL with
<150% increase in creatinine from baseline) are associated
with a 3.9-fold increase in 30-day all-cause postoperative
mortality relative to a negative change in serum creatinine.
Although a small change in postoperative creatinine has
been previously reported to be predictive of increased early
mortality after cardiac surgery, earlier studies did notrdiovascular Surgery c Volume 143, Number 3 685
FIGURE 1. Multivariate logistic regression analysis of risk factors for 30-day all-cause mortality after coronary artery bypass grafting with cardiopulmo-
nary bypass. CI, Confidence interval; RI, renal insufficiency; PVD, peripheral vascular disease; CHF, congestive heart failure; MI, myocardial infarction.
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Mcontrol for preoperative RF and were potentially con-
founded by inclusion of multiple types of cardiothoracic
surgical procedures.3,4 In contrast to previous findings, we
did not observe an increase in mortality as the change in
serum creatinine became more negative, as had been
previously reported.3,4 In addition, our study suggests that
change in serum creatinine does not predict mortality in
patients with severe preoperative RI. Although the
underlying mechanism is not clear, we suspect that
perioperative hemodilution and hydration after cardiac
surgery may offset the changes in serum creatinine in
patients with severe preoperative RI and high baseline
creatinine levels. Nevertheless, the early diagnosis of AKIFIGURE 2. The 30-day all-cause mortalities for each change in serum
creatinine (DCreatinine) level in a combined group of patients with normal
preoperative renal function and patients with mild and moderate preopera-
tive renal insufficiency.
686 The Journal of Thoracic and Cardiovascular Surgmay not be relevant in patients with severe preoperative
RI, because those patients already have late-stage kidney
damage and probably face irreversibly high perioperative
mortality risk.12,13
In our study, patients with a postoperative negative
change in serum creatinine accounted for approximately
50% of the patient population who underwent CABG
with CPB. It is interesting to note that these patients had
the lowest postoperative mortality after the surgery. Al-
though our study was not designed to delineate the patho-
physiologic mechanisms responsible for changes in
perioperative serum creatinine levels, we hypothesize that
increases in postoperative creatinine (a positive change in
serum creatinine) may indicate a state of global tissue hypo-
perfusion. Another mechanism that might explain why
small postoperative changes in serum creatinine levels can
independently predict increased 30-day all-cause mortality
after CABGwith CPB is that small rises in serum creatinine
may be an early marker for evolving kidney damage, with
progressive rises in serum creatinine levels indicative of
a more serious global insult that affects multiple other end
organs.
Serum creatinine is not protein bound, is physiologically
inert, and is structurally stable without being further metab-
olized. Moreover, serum creatinine is produced solely
through muscle creatinine dehydration and is eliminated
through the kidneys.14 Thus serum creatinine may fulfill
many criteria for a sensitive and reliable biomarker of RF
after cardiac surgery. When patients have normal perfusion
of the tissue and preserved kidney function after cardiac sur-
gery with CPB, variability of serum creatinine concentra-
tion may be minimal as a result of normal production and
excretion of creatinine. In our study, the slight decreasedery c March 2012
FIGURE 3. Multivariate analysis of 30-day all-cause mortality. Significant independent predictors along with their associated odds ratios and 95% con-
fidence intervals (CIs) are shown. Patients with subclinical increases in serum creatinine (group C) were independently associated with a higher risk of
30-day all-cause mortality. Mod Pre-op RI, Moderate preoperative renal insufficiency; CHF, congestive heart failure.
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Mlevels of postoperative serum creatinine observed in ap-
proximate 50% of the patients likely reflect the effects of
normal hemodilution and perioperative hydration after
CABG with CPB. This may explain why those patients
with negative changes in serum creatinine had the lowest
mortality in our study. In contrast, a rise in serum creatinine
may indicate decreased excretion of creatinine as a result of
decreasing GFR or increased production of creatinine after
prolonged skeleton muscle ischemia.15 A slight change in
serum creatinine (0–0.2 mg/dL) after cardiac surgery with
CPB may thus served to mark a group of patients with early
stages of organ dysfunction or tissue hypoperfusion. At
present, subclinical changes in serum creatinine (0–0.2
mg/dL) after cardiac surgery are often neglected with
respect to clinical management. Our current findings there-
fore may highlight the importance of further investigation
of serum creatinine as a sensitive and early perioperative
marker to be used in outcome management after cardiac
surgery.
In contrast to patients with subclinical changes in creati-
nine, patients with postoperative AKI (defined by AKIN6 or
RIFLE7 Criteria) were associated with a 14 fold increase in
postoperative mortality (OR, 14.68; 95% CI, 6.42–33.62;
P< .01). This may reflect severe kidney or multiorgan
injury, resulting in increased 30-day all cause mortality.
Cardiac surgery–associated AKI is the second most com-
mon cause of AKI in critically ill patients, and it is well rec-
ognized as a risk factor for mortality after cardiac
surgery.4,16,17 To date, however, there is no proven
preventive strategy or treatment for AKI after cardiac
surgery. It is therefore imperative to develop a biomarker
for early diagnosis of AKI that will allow management toThe Journal of Thoracic and Caminimize postoperative morbidity and mortality.
Historically, serum creatinine has been considered to be
a relatively late biomarker for AKI, because there are
known deficiencies with using serum creatinine levels
during acute changes in RF.14,18,19 Recently, several novel
biomarkers have been developed to improve the
sensitivity and specificity of the early diagnosis of AKI.
Neutrophil gelatinase–associated lipocalin, kidney injury
molecule 1, and interleukin 18 are all novel biomarkers
currently being investigated to improve our ability to
diagnose AKI in its earliest stages.20-23 These new
biomarkers may be capable of detecting AKI within hours
of the initial kidney injury and have specifically been
examined in patients undergoing cardiac surgery, with
promising results.20,22,23 Nevertheless, our results suggest
that irrespective of serum creatinine’s utility as a marker
for acute changes in RF, serum creatinine is a sensitive
and significant biomarker for prediction of 30-day all-
cause mortality in patients undergoing CABG with CPB.
Although this study contributes to the literature regarding
biomarkers and outcomes after CABG with CPB, there are
several limitations that must be considered. First, this was
a retrospective cohort study, and enrollment was neither
prospective nor randomized. We believe that it is important
to perform a prospectively designed study to investigate
perioperative creatinine kinetics in patients with normal
RF and varying levels of preoperative RI undergoing
CABG with CPB. Second, although appropriate statistical
models were used in analyzing the data, there still remains
the possibility that unmeasured factors may have affected
the outcomes. Third, serum creatinine levels were only fol-
lowed for the first 48 hours postoperatively, and this limitedrdiovascular Surgery c Volume 143, Number 3 687
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Mtime frame may have missed serum creatinine changes that
happened beyond the first 48 hours after surgery but none-
theless may have affected 30-day all cause mortality.
In conclusion, serum creatinine changes in the periopera-
tive period may be a sensitive biomarker for predicting 30-
day all cause mortality in patients undergoing CABG with
CPB. Importantly, even small subclinical positive increases
in serum creatinine that do not meet the AKI criteria as de-
fined by AKIN6 or RIFLE7 criteria were associated with
a 3.9 fold increase in 30-day all-cause postoperative mortal-
ity. Thus subclinical serum creatinine changes after CABG
with CPBmay provide an early warning of the need for clin-
ical intervention. Future prospective studies are needed to
evaluate the effectiveness of clinical interventions made on
the basis of serum creatinine changes after CABGwith CPB.
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TABLE E1. Criteria for acute kidney injury
Serum creatinine and
GFR criteria Urinary output criteria
AKIN stage
1 Increase in serum creatinine 0.3 mg/dL or increase 150%–200%
from baseline
<0.5 mL/(kg $ h) for 6 h
2 Increase in serum creatinine>200%–300% from baseline <0.5 mL/(kg $ h) for 12 h
3 Increase in serum creatinine>300% from baseline or4.0 mg/dL with
an acute rise>0.5 mg/dL
<0.3 mL/(kg $ h) 24 hours or
anuria 12 hours
RIFLE criteria
Risk 1.5-fold increase in serum creatinine or>25% decrease in GFR <0.5 mL/(kg $ h) for 6 h
Injury 2-fold increase in serum creatinine or>50% decrease in GFR <0.5 mL/(kg $ h) for 12 h
Failure 3-fold increase in serum creatinine or serum creatinine 4 mg/dL or
75% decrease in GFR
<0.3 mL/(kg $ h) for 24 h or
anuria for 12 h
Loss Total loss of kidney function for 4 wk
End-stage kidney disease End-stage kidney disease for 3 mo
AKIN, Acute Kidney Injury Network (criteria for acute kidney injury adopted fromMehta and colleagues6);GFR, glomerular filtration rate; RIFLE, risk, injury, failure, loss, and
end-stage kidney disease (criteria for the diagnosis of acute kidney injury adopted from Bellomo and associates7).
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